Bone marrow mesenchymal stromal cell therapy for external urethral sphincter restoration in a rat model of stress urinary incontinence

Neurourology and Urodynamics

Volumn 30, Issue 3, 2011, Pages 447-455

  Corcos, Jacques ^a   Loutochin, Oleg ^a,b   Campeau, Lysanne ^a   Eliopoulos, Nicoletta ^b   Bouchentouf, Manaf ^b   Blok, Bertil ^a   Galipeau, Jacques ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Bone marrow mesenchymal stromal cells; Calponin; Desmin; External urethral sphincter deficiency; Leak point pressure measurement; Regenerative medicine; SMA; Stress urinary incontinence

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; DESMIN; MEMBRANE ANTIGEN; MYOSIN HEAVY CHAIN; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER SPHINCTER; CELL DIFFERENTIATION; CONTROLLED STUDY; CYSTOMETRY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELL TRANSPLANTATION; MUSCLE CELL; NONHUMAN; PHENOTYPE; PROTEIN BLOOD LEVEL; PUDENDAL NERVE; RAT; STRESS INCONTINENCE; URETHRA;

ANALYSIS OF VARIANCE; ANIMALS; ATROPHY; BIOLOGICAL MARKERS; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOHISTOCHEMISTRY; INJECTIONS; MESENCHYMAL STEM CELL TRANSPLANTATION; PHENOTYPE; PRESSURE; RATS; RATS, SPRAGUE-DAWLEY; REGENERATION; TIME FACTORS; URETHRA; URINARY INCONTINENCE, STRESS; URODYNAMICS;

EID: 79952770377     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.20998     Document Type: Article

References (35)

1. Melville JL, Katon W, Delaney K, et al. Urinary incontinence in US women: A population-based study. Arch Intern Med 2005;165:537-42. (Pubitemid 40344385)
2. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology in lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society. Urology 2003;61:37-49. (Pubitemid 36151708)
3. Fultz N, Girts T, Kinchen K, et al. Prevalence, management and impact of urinary incontinence in the workplace. Occup Med (Lond) 2005;55:552-57. (Pubitemid 41683682)
4. Strasser H, Tiefenthaler M, Steinlechner M, et al. Age dependent apoptosis and loss of rhabdosphincter cells. J Urol 2000;164:1781-85.
5. Damaser MS, Broxton-King C, Ferguson C, et al. Functional and neuroanatomical effects of vaginal distention and pudendal nerve crush in the female rat. J Urol 2003;170:1027-31. (Pubitemid 36999626)
6. Lin YH, Liu G, Daneshgari F. A mouse model of simulated birth trauma induced stress urinary incontinence. Neurourol Urodyn 2008;27:353-58. (Pubitemid 351656409)
7. Rodriguez LV, Chen S, Jack GS, et al. New objective measures to quantify stress urinary incontinence in a novel durable animal model of intrinsic sphincter deficiency. Am J Physiol Regul Integr Comp Physiol 2005;288: R1332-38.
8. Hijaz A, Daneshgari F, Sievert KD, et al. Animal models of female stress urinary incontinence. J Urol 2008;179:2103-10.
9. Chancellor MB, Yoshimura N. Neurophysiology of stress urinary incontinence. Rev Urol 2004;6:S19-28.
10. Peng CW, Chen JJ, Chang HY, et al. External urethral sphincter activity in a rat model of pudendal nerve injury. Neurourol Urodyn 2006;25:388-96.
11. Shortliffe LM, Freiha FS, Kessler R, et al. Treatment of urinary incontinence by the periurethral implantation of glutaraldehyde cross-linked collagen. J Urol 1989;141:538-41. (Pubitemid 19089145)
12. Ghoniem G, Corcos J, Comiter C, et al. Durability of urethral bulking agent injection for female stress urinary incontinence: 2-Year multicenter study results. J Urol 183:1444-49.
13. Madjar S, Sharma AK, Waltzer WC, et al. Periurethral mass formations following bulking agent injection for the treatment of urinary incontinence. J Urol 2006;175:1408-10.
14. Strasser H, Marksteiner R, Margreiter E, et al. Transurethral ultrasonography-guided injection of adult autologous stem cells versus transurethral endoscopic injection of collagen in treatment of urinary incontinence. World J Urol 2007;25:385-92.
15. Smaldone MC, Chancellor MB. Muscle derived stem cell therapy for stress urinary incontinence. World J Urol 2008;26:327-32.
16. Roche R, Festy F, Fritel X. Stem cells for stress urinary incontinence: The adipose promise. J Cell Mol Med 2010;14:135-42.
17. Keating A. Mesenchymal stromal cells. Curr Opin Hematol 2006;13:419-25. (Pubitemid 44607442)
18. Eliopoulos N, Stagg J, Lejeune L, et al. Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice. Blood 2005;106:4057-65. (Pubitemid 41775910)
19. Copland I, Sharma K, Lejeune L, et al. CD34 expression on murine marrow-derived mesenchymal stromal cells: Impact on neovascularization. Exp Hematol 2008;36:93-103. (Pubitemid 350266974)
20. Levy YS, Bahat-Stroomza M, Barzilay R, et al. Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease. Cytotherapy 2008;10:340-52. (Pubitemid 351983158)
21. Kocher AA, Schlechta B, Gasparovicova A, et al. Stem cells and cardiac regeneration. Transpl Int 2007;20:731-46. (Pubitemid 47221056)
22. Gong Z, Niklason LE. Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs). FASEB J 2008;22:1635-48. (Pubitemid 351811442)
23. De Coppi P, Callegari A, Chiavegato A, et al. Amniotic fluid and bone marrow derived mesenchymal stem cells can be converted to smooth muscle cells in the cryo-injured rat bladder and prevent compensatory hypertrophy of surviving smooth muscle cells. J Urol 2007;177:369-76. (Pubitemid 44879501)
24. Shukla D, Box GN, Edwards RA, et al. Bone marrow stem cells for urologic tissue engineering. World J Urol 2008;26:341-49.
25. Anumanthan G, Makari JH, Honea L, et al. Directed differentiation of bone marrow derived mesenchymal stem cells into bladder urothelium. J Urol 2008;180:1778-83.
26. Dai W, Hale SL, Martin BJ, et al. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: Short- and long-term effects. Circulation 2005;112:214-23. (Pubitemid 40982304)
27. Becker C, Laeufer T, Arikkat J, et al. TGFb1 and epithelial-mesenchymal interactions promote smooth muscle gene expression in bone marrow stromal cells: Possible application in therapies for urological defects. Int J Artif Organs 2008;31:951-59.
28. Copland IB, Jolicoeur EM, Gillis MA, et al. Coupling erythropoietin secretion to mesenchymal stromal cells enhances their regenerative properties. Cardiovasc Res 2008;79:405-15.
29. Yiou R, Yoo JJ, Atala A. Restoration of functional motor units in a rat model of sphincter injury by muscle precursor cell autografts. Transplantation 2003; 76:1053-60. (Pubitemid 37280833)
30. Spees JL, Whitney MJ, Sullivan DE, et al. Bone marrow progenitor cells contribute to repair and remodeling of the lung and heart in a rat model of progressive pulmonary hypertension. FASEB J 2008;22:1226-36. (Pubitemid 351519976)
31. Lee RH, Seo MJ, Reger RL, et al. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci USA 2006;103: 17438-43. (Pubitemid 44788987)
32. Li Z, Guo J, Chang Q, et al. Paracrine role for mesenchymal stem cells in acute myocardial infarction. Biol Pharm Bull 2009;32:1343-46.
33. Noel D, Caton D, Roche S, et al. Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials. Exp Cell Res 2008;314:1575-84.
34. Cevallos M, Riha GM, Wang X, et al. Cyclic strain induces expression of specific smooth muscle cell markers in human endothelial cells. Differentiation 2006;74:552-61. (Pubitemid 44922500)
35. Togel F, Westenfelder C. Adult bone marrow-derived stem cells for organ regeneration and repair. Dev Dyn 2007;236:3321-31. (Pubitemid 350276389)